
Sustained Therapeutics Showcases Positive Phase 2 ST-01 Results at AUA 2026 Annual Meeting
Sustained Therapeutics Highlights Positive Mid-Stage Clinical Outcomes for Its Investigational Therapy ST-01 Sustained Therapeutics has reported additional positive findings from its Phase 2 clinical study evaluating ST-01, the company’s proprietary non-opioid sustained-release therapy for men suffering from chronic scrotal content…











